Maybe there will be a great anns on Monday, maybe not.
Maybe some FMG money will flow into AHZ, maybe not.
Maybe some big guys are taking / increasing a position, maybe not.
But:
Cardiocel is a world leading product and has started to be sold and will sell even more worldwide,
economic crises or not, health will always be a priority.
Therefore just the success of Cardiocel and its related applications alone already justifies a higher sp.
And, on top of that, take the herpes vaccine development into account ..... - you can do the maths.
GLTA, if not Monday, then soon.
Nice finish, page-14
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.73 |
Change
-0.180(1.01%) |
Mkt cap ! $340.8M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.73 | $50.92K | 2.848K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 62 | $17.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.87 | 3 | 2 |
View Market Depth
| Last trade - 14.04pm 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |